| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/02/2008 | EP1904517A1 Artificial protein, method for absolute quantification of proteins and uses thereof |
| 04/02/2008 | EP1904087A2 Use of mas g-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for prevention and treatment of diseases |
| 04/02/2008 | EP1904084A2 Methods of protecting against apoptosis using lipopeptides |
| 04/02/2008 | EP1009824B1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-kappaB ACTIVATION |
| 04/02/2008 | CN101155825A Antimicrobial hexapeptides |
| 04/02/2008 | CN101153056A Regrouped anticancer peptide, producing method and application of the same |
| 04/02/2008 | CN101153055A Novel peptide with angiotonin transferase restraining liveness and method of producing the same |
| 04/02/2008 | CN101153054A Peptide for treatment of vascellum generation and uses thereof |
| 04/02/2008 | CN101152574A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN101152573A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN100378122C B lymphocyte stimulus factor inhibiting peptide and its screening and preparing method |
| 04/02/2008 | CN100378121C Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/01/2008 | USRE40198 Method and device for electrochemical immunoassay of multiple analytes |
| 04/01/2008 | US7351807 Cyanine-sulfenates for dual phototherapy |
| 04/01/2008 | US7351792 G-protein coupled receptor for use as tool in identify modulators which prevent serine protease activation in response to trauma and immune system attack |
| 04/01/2008 | US7351791 Intermediate for preparing glycopeptide derivatives |
| 04/01/2008 | US7351790 Peptide-based compounds |
| 04/01/2008 | US7351693 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 04/01/2008 | US7351687 Peptide structure containing lanthionine and methyllanthionine as constituents isolated from Microbispora sp. ATCC PTA-5024; methicillin resistant and vancomycin resistant bacteria; M. catharralis, Neisseria species and H. influenzae and Mycobacteria |
| 04/01/2008 | US7351409 Tumor antigens and CTL clones isolated by a novel procedure |
| 03/27/2008 | WO2008036761A2 Anti-microbial defensin-related peptides and methods of use |
| 03/27/2008 | WO2008035093A2 Peptides |
| 03/27/2008 | WO2008034161A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor |
| 03/27/2008 | WO2008003943A3 Inhibition of alpha-synuclein aggregation |
| 03/27/2008 | WO2004069200A3 Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
| 03/27/2008 | WO2003075845A3 Immunogenicity of glucan binding protein |
| 03/27/2008 | US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/27/2008 | US20080076718 oligopeptide or polypeptide amino acid sequences as biodrug antitumor agents, anticarcinogenic agents; treating autoimmune diseases, AIDS, inflammatory diseases, cardiovascular disorder of ischemic processes, allograft rejection, cerebral strokes, traumas, burns, Alzheimer's disease, Parkinson's disease |
| 03/27/2008 | US20080076717 Polypeptides for bone mineralization |
| 03/27/2008 | US20080076716 Anti-Microbial Defensin-Related Peptides and Methods of Use |
| 03/27/2008 | US20080076713 Peptides selectively lethal to malignant and transformed mammalian cells |
| 03/27/2008 | US20080075738 synthetic polypeptide biodrugs for treating viral disease; envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 03/27/2008 | US20080075725 Novel Immunointeractive Molecules and uses Thereof |
| 03/27/2008 | CA2664064A1 Internally-constrained cyclic oligopeptides |
| 03/27/2008 | CA2663545A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof |
| 03/26/2008 | EP1901761A2 Thrombospondin-1 derived peptides and treatment methods |
| 03/26/2008 | EP0917535B1 Neuroactive peptide |
| 03/26/2008 | EP0885242B1 Peptides and compounds that bind to a thrombopoietin receptor |
| 03/26/2008 | CN101151273A Acid addition salts of Ac-PHSCN-NH2 |
| 03/26/2008 | CN101151054A Radiofluorinated peptides |
| 03/26/2008 | CN101148470A Antibacterial/neutral endotoxin allosteric peptide molecule modified by polyglycol, synthesizing method and medical use thereof |
| 03/26/2008 | CN100376597C Polypeptide for decreasing blood pressure, its separation method and uses |
| 03/26/2008 | CN100376570C Dioxolane analogs for improved inter-cellular delivery |
| 03/25/2008 | US7348405 PRO10274 polypeptides |
| 03/25/2008 | US7348404 Solid-phase peptide synthesis and agent for use in such synthesis |
| 03/25/2008 | US7348402 Antimicrobial peptide, its analogs and antimicrobial composition comprising them |
| 03/25/2008 | US7348401 Peptides that inhibit complement activation |
| 03/25/2008 | US7348400 α-conotoxin peptides with analgesic properties |
| 03/25/2008 | US7348311 Derivatives of dehydrodidemnin B |
| 03/25/2008 | US7348310 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 03/25/2008 | US7348308 Polypeptides biodrugs with given amino acid sequence which includes phosphorylated serine or threonine; Type II Diabetes and Alzheimer's Disease |
| 03/25/2008 | US7348306 Peptide with a sequence selected from the group consisting of Ser-Leu-Ile-Gly-Arg-Leu-NH2, and trans-cynnamoyl-Leu-Ile-Gly-Arg-Leu-ornithine-NH2 combined with amastatins for activation of protease activated receptor-2; eye drop solution for contact lenses |
| 03/25/2008 | US7348010 Contains at least one peptide with a length of 9 to 25 amino acids and a sequence as occurs in extracellular doamin of HER-2/neu protein, and the peptide or functional variants conjugated to an immunogenic carrier |
| 03/25/2008 | CA2385533C Polymer stabilized neuropeptides |
| 03/25/2008 | CA2333145C Drug delivery system comprising a homeobox peptide and a non-peptide, non-nucleotide drug |
| 03/25/2008 | CA2217679C Peptides and therapeutic agent for autoimmune diseases containing the same |
| 03/20/2008 | WO2008033488A2 Polypeptides for bone mineralization |
| 03/20/2008 | WO2008032783A1 Artificial antibacterial peptide and use thereof |
| 03/20/2008 | WO2008012102A3 Radiodense conjugate |
| 03/20/2008 | WO2007103739A3 Methods and compositions related to cyclic peptide synthesis |
| 03/20/2008 | WO2004111075A3 Alternative reading frame polypeptides for treatment |
| 03/20/2008 | US20080071062 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 03/20/2008 | US20080070853 Peptides Selectively Lethal to Malignant and Transformed Mammalian Cells |
| 03/20/2008 | US20080070843 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 03/20/2008 | US20080070835 Hla-Dr-Binding Antigen Peptide Derived From Wt1 |
| 03/20/2008 | US20080070279 Group of Synthetic Antimicrobal Peptides |
| 03/20/2008 | US20080069866 Immunotherapeutic methods and compositions |
| 03/20/2008 | US20080069815 Autoimmune diseases; rheumatic arthritis |
| 03/20/2008 | US20080069812 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 03/19/2008 | EP1901069A1 Fret protease assays for clostridial toxins |
| 03/19/2008 | EP1898942A2 Antiproliferative peptides and antibodies for their detection |
| 03/19/2008 | EP1575991A4 Peptides comprising aromatic d-amino acids and methods of use |
| 03/19/2008 | EP1282437B1 Treatment of cartilage disorders |
| 03/19/2008 | EP0980240B1 Sustained-release compositions and method for preparing same |
| 03/19/2008 | CN101143895A Polypeptide with tumour targeting effects and preparation method thereof |
| 03/19/2008 | CN101143894A Highly effective polypeptide for inhibiting angiogenesis, physical chemistry modifying method and application thereof |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345144 Melanocortin receptor-specific hexapeptides |
| 03/18/2008 | US7345022 Anti-fibril peptides |
| 03/18/2008 | US7344884 Fibronectins; fibroblast growth factors |
| 03/18/2008 | US7344879 Peptide for use in the treatment of cell proliferation disorders |
| 03/18/2008 | US7344721 Polypeptide for the treatment of cancer and a method for preparation thereof |
| 03/18/2008 | US7344714 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 03/18/2008 | CA2189145C Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 03/13/2008 | WO2008031091A2 A surface-based ammonium ion sensor: an electrode derivatized with a self-assembled monolayer |
| 03/13/2008 | WO2008031064A1 Hyd1 peptides as anti-cancer agents |
| 03/13/2008 | WO2008028688A2 Compounds and methods for 18f labeled agents |
| 03/13/2008 | WO2008028530A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 03/13/2008 | WO2007143735A3 Polycationic sulfonamides and use thereof |
| 03/13/2008 | WO2007133623A3 Peptide diagnostic agent for lyme disease |
| 03/13/2008 | US20080064854 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/13/2008 | US20080064643 Peptidomimetic antagonists prevent signalling interference of the TLR/IL-R1 receptor system; antiinflammatory agents; autoimmune diseases; cardiovascular and atherogenic diseases; sepsis and shock; transplant rejection |
| 03/13/2008 | US20080064642 Excellent receptivity, pharmacokinetics, enzyme resistance with capability to significantly prevent and treat conditions wherein BKB1Rs are induced and over-expressed |
| 03/13/2008 | US20080064641 Thr-ala-leu-arg-ile-arg-ala-thr-tyr-gly-glu-tyr, a fragment of the gamma 2 chain of laminin 5, has high biopermeability therough the epidermis and increases cellular adhesion; increases skin aging and wrinkle resistance, elasticity, healing, vascularization; cosmetics |
| 03/13/2008 | US20080063653 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063601 treatment of urogenital disorders comprising administering calcium channel blockers, such as triptolide, prodrugs and/or derivatives |
| 03/13/2008 | US20080063598 chimeric antibodies, fragments, polypeptides and derivatives that preferentially bind tumor associated antigens (AF-20), useful in the treatment and diagnosis of cancers |
| 03/13/2008 | US20080063585 Fullerene nanotube compositions |